Balyasny Asset Management
LMAT icon

Balyasny Asset Management’s LeMaitre Vascular LMAT Stock Holding History

Balyasny Asset Management’s Portfolio LMAT Stock Details LMAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-33,536
Closed -$3.09M – 3069
2024
Q4 		$3.09M Buy
+33,536
New +$3.23M ﹤0.01% 1498
2024
Q1 		– Sell
-7,493
Closed -$425K – 2893
2023
Q4 		$425K Sell
7,493
-40,016
-84% -$2.1M ﹤0.01% 2012
2023
Q3 		$2.59M Buy
+47,509
New +$2.82M 0.01% 1312
2022
Q4 		– Sell
-10,355
Closed -$525K – 3026
2022
Q3 		$525K Buy
+10,355
New +$517K ﹤0.01% 2022
2018
Q3 		– Sell
-6,600
Closed -$221K – 1877
2018
Q2 		$221K Buy
+6,600
New +$235K ﹤0.01% 1619
2016
Q1 		– Sell
-29,360
Closed -$506K – 1412
2015
Q4 		$506K Buy
29,360
+11,960
+69% +$173K ﹤0.01% 827
2015
Q3 		$212K Buy
17,400
+6,525
+60% +$83.7K ﹤0.01% 998
2015
Q2 		$131K Buy
+10,875
New +$107K ﹤0.01% 1057

Other funds holding LMAT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Balyasny Asset Management's LMAT Position: Q1 2025 in Review

Balyasny Asset Management sold out of LeMaitre Vascular (LMAT) in Q1 2025, closing a stake of 33,536 shares — an estimated $3.09M sold.

Balyasny Asset Management first reported a position in LMAT in Q2 2015 and held it in 8 quarters. The position peaked at $3.09M in Q4 2024. 288 funds tracked by Wall St. Rank hold LMAT as of Q1 2025.

  • Balyasny Asset Management reported no remaining LeMaitre Vascular position as of Q1 2025 after selling out during the quarter.
  • Balyasny Asset Management sold 33,536 LeMaitre Vascular shares in Q1 2025, an estimated $3.09M.
  • Balyasny Asset Management first reported a position in LeMaitre Vascular in Q2 2015 and held it in 8 quarters.
  • Balyasny Asset Management's LeMaitre Vascular position peaked at $3.09M in Q4 2024.
  • 288 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2025.

Based on Balyasny Asset Management's 13F filing for Q1 2025, filed 15 May 2025.